Lrig1 anticorps (AA 35-220)

N° du produit ABIN6143319

Détail du produit anti-Lrig1 anticorps

Antigène: Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))

Épitope: AA 35-220

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Lrig1 est non-conjugé

Application: Western Blotting (WB)

Séquence: AGPRAPCAAA CTCAGDSLDC GGRGLAALPG DLPSWTRSLN LSYNKLSEID PAGFEDLPNL QEVYLNNNEL TAVPSLGAAS SHVVSLFLQH NKIRSVEGSQ LKAYLSLEVL DLSLNNITEV RNTCFPHGPP IKELNLAGNR IGTLELGAFD GLSRSLLTLR LSKNRITQLP VRAFKLPRLT QLDLNR

Réactivité croisée: Humain, Souris

Attributs du produit: Polyclonal Antibodies

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 35-220 of human LRIG1 (NP_056356.2).

Isotype: IgG

Information d'application

Indications d'application: WB,1:1000 - 1:2000

Commentaires:

HIGH QUALITY

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur Lrig1

Antigène: Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))

Autre désignation: LRIG1 (Lrig1 Produits)

Synonymes: anticorps LIG-1, anticorps LIG1, anticorps D6Bwg0781e, anticorps Img, anticorps leucine rich repeats and immunoglobulin like domains 1, anticorps leucine-rich repeats and immunoglobulin-like domains 1, anticorps LRIG1, anticorps Lrig1

Sujet: Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.,LRIG1,LIG-1,LIG1,Cancer,Tumor suppressors,LRIG1

Poids moléculaire: 116 kDa/119 kDa

ID gène: 26018

UniProt: Q96JA1